Oncology in the Middle East Market
Over the past decade, there has been a paradigm shift in the treatment of cancer, driven by advances in personalized medicine and immuno-oncology. The global oncology market is expected to continue growing at 9% between 2016 and 2021, one of the highest forecasted growth rates among ATC1s. The focus on oncology will remain high over the next decade driven by the ongoing research and development and remaining unmet need. In the Middle East too, oncology has become an area where pharma companies are investing a lot of resources and efforts; it was the 6th highest selling and the 2nd fastest growing therapy area in MAT Q3 2017.